Health secretary cites ‘new data’ that emerged from flawed study conservatives are using to pressure US government
Susan Rinkunas
Wed 14 May 2025
The US health secretary, Robert F Kennedy Jr, said on Wednesday that he had directed the FDA to review the regulations around the abortion pill mifepristone.
The review, he said, was necessary due to “new data” – data that emerged from a flawed analysis that top US anti-abortion groups are now using to pressure the Trump administration to reimpose restrictions on the abortion pill, if not pull it from the market entirely.
“It’s alarming,” Kennedy told the Missouri senator Josh Hawley, a Republican, during a congressional hearing. “Clearly, it indicates that, at very least, the label should be changed.”
Continued: https://www.theguardian.com/us-news/2025/may/14/rfk-jr-fda-abortion-pill-mifepristone